Telehealth Education for Asthma Connecting Hospital and Home
TEACHH
1 other identifier
interventional
26
1 country
1
Brief Summary
The goal of this study is to evaluate the feasibility, acceptability, and preliminary efficacy of a technology-enhanced educational intervention for caregivers and children who are hospitalized due to asthma. We will conduct a pilot RCT with 60 children (5-13 yrs) hospitalized with asthma at the Golisano Children's Hospital in Rochester, NY. After baseline assessment, subjects will be randomized to either: 1) the Telehealth Education for Asthma Connecting Hospital and Home (TEACHH) intervention, which includes inpatient child/caregiver education using pictorial materials, color/shape labels for home medications (green star=controller, yellow/red circles=rescue), and a pair of in-home, smartphone-based telehealth visits after discharge to reinforce effective home management; or, 2) the standard care (SC) condition, which features standard inpatient education and routine outpatient follow-up. Patients in TEACHH will also receive all SC measures. All caregivers will complete blinded telephone follow-up assessments at 2, 4, and 6 months after discharge; children will be asked medication questions at baseline and 6 months. We will describe the feasibility and acceptability of implementing the TEACHH intervention by reviewing process measure data collected throughout the study; assess the preliminary efficacy of TEACHH in improving key clinical outcomes, including asthma-related ACU at 7 days, 30 days, and 6 months (per electronic health record documentation) and symptom-free days at each follow-up (reported by caregivers); and assess secondary clinical and functional outcomes including asthma-related quality of life, missed school or work due to asthma, caregiver and child medication knowledge, and reported adherence. We will also invite all caregivers to complete a semi-structured qualitative interview (1 month after baseline for the TEACHH group, 6 months after baseline for the SC group). Findings from this work will establish a strong foundation for a full-scale trial, and guide future efforts to deliver guideline-based asthma care to underserved children and families at the greatest risk for preventable morbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2021
CompletedFirst Posted
Study publicly available on registry
August 9, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedNovember 28, 2023
November 1, 2023
1.2 years
July 14, 2021
November 24, 2023
Conditions
Outcome Measures
Primary Outcomes (6)
Asthma-related hospitalizations and emergency department visits after discharge
Asthma-related hospitalizations or emergency department visits, and drawn from objective healthcare utilization data in the electronic health record.
7 days after discharge
Asthma-related hospitalizations and emergency department visits after discharge
Asthma-related hospitalizations or emergency department visits, and drawn from objective healthcare utilization data in the electronic health record.
30 days after discharge
Asthma-related hospitalizations and emergency department visits after discharge
Asthma-related hospitalizations or emergency department visits, and drawn from objective healthcare utilization data in the electronic health record.
6 months after discharge
Symptom-Free Days (SFD) in the past 2 weeks
The number of 24-hour periods within the previous 14 days that a child remained free of asthma symptoms (range: 0-14 days); a higher score indicates more days without symptoms. Reported by caregivers during scheduled telephone assessments (2, 4, and 6 months after discharge)
2 months
Symptom-Free Days (SFD) in the past 2 weeks
The number of 24-hour periods within the previous 14 days that a child remained free of asthma symptoms (range: 0-14 days); a higher score indicates more days without symptoms. Reported by caregivers during scheduled telephone assessments (2, 4, and 6 months after discharge)
4 months
Symptom-Free Days (SFD) in the past 2 weeks
The number of 24-hour periods within the previous 14 days that a child remained free of asthma symptoms (range: 0-14 days); a higher score indicates more days without symptoms. Reported by caregivers during scheduled telephone assessments (2, 4, and 6 months after discharge)
6 months
Secondary Outcomes (7)
Caregiver-reported Asthma-related Acute Care Utilization (ACU)
7 days, 30 days, and 6 months after discharge
Caregiver-reported Asthma-related outpatient care
2 months, 4 months, and 6 months
Caregiver-reported Asthma control (NHLBI)
2 months, 4 months, and 6 months
Caregiver quality of life
2 months, 4 months, 6 months
Missed school due to asthma in the past 2 weeks
2 months, 4 months, 6 months
- +2 more secondary outcomes
Study Arms (2)
Telehealth Education for Asthma Connecting Hospital and Home (TEACHH)
EXPERIMENTALNew model of patient-centered asthma education
Standard Care (SC) Comparison Group
ACTIVE COMPARATORStandard inpatient asthma education per hospital protocol.
Interventions
TEACHH aims to provide educational support to families managing childhood asthma throughout the transition from hospital to home, and includes several core components: 1) Health literacy-informed inpatient teaching for child and caregiver including pictorial materials, hands-on demonstration, and use of teach-back/show-back techniques; 2) Facilitated identification of rescue and controller medications using color- and shape-coded medication labels and a pictorial asthma action plan; and 3) A pair of virtual follow-up visits after discharge to reinforce inpatient teaching and support families during the shift from acute exacerbation to preventive care management. Virtual visits will be completed using the Zoom platform on smartphones or other compatible devices, 2-4 days after discharge (first visit) and 3 weeks after discharge (second visit). All intervention activities will be completed within 1 month of discharge.
Patients in the SC group will receive standard impatient management, including pre-recorded asthma education videos shown prior to discharge and the hospital action plan. PCP follow-up with be scheduled within a week of discharge. All SC measures will also be provided to subjects randomized to TEACHH.
Eligibility Criteria
You may qualify if:
- Physician diagnosis of asthma, based on review of medical records.
- Inpatient admission to GCH with asthma as a primary or secondary diagnosis.
- Persistent asthma or poor asthma control for which a daily controller medication is recommended by NHLBI guidelines, defined as any 1 of the following:
- \>2 days per week with asthma symptoms in the past month;
- \>2 days per week with rescue medication use in the past month;
- \>2 days per month with nighttime symptoms in the past month; or
- ≥1 other episode(s) of asthma during the past year that required systemic corticosteroids
- Age between ≥5 and ≤11 years.
You may not qualify if:
- An inability to speak and understand English. Parents and children with low literacy / health-literacy skills will be eligible, as survey instruments will be administered verbally and educational materials will be designed for low-literacy populations.
- No access to a working phone for follow-up survey assessments.
- No access to a smartphone (or other 'smart' device) for telehealth education.
- Another significant medical condition, including Cystic Fibrosis, congenital heart disease, or other chronic lung disease, that could interfere with assessment of asthma-related measures.
- A diagnosed developmental condition (e.g. Autism spectrum disorder or significant developmental delay) identified in the child's medical record that could interfere with a child's ability to participate in teaching activities, and/or potentially delay the transition of responsibility for inhaled asthma medications from caregiver to child.
- If the child or family is currently enrolled in a study conducted by The Preventive Care Program for Urban Children with Asthma (led by Dr. Jill Halterman).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Rochesterlead
- Agency for Healthcare Research and Quality (AHRQ)collaborator
- American Lung Associationcollaborator
Study Sites (1)
University of Rochester Medical Center
Rochester, New York, 14642, United States
Related Publications (1)
Frey SM, Sanchez I, Fagnano M, Milne Wenderlich A, Mammen JR, Halterman JS. The Telehealth Education for Asthma Connecting Hospital and Home (TEACHH) pilot study. J Asthma. 2025 Mar;62(3):416-426. doi: 10.1080/02770903.2024.2408304. Epub 2024 Oct 9.
PMID: 39352693DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Research assistants conducting telephone follow-up assessments 2, 4, and 6 months after enrollment will be blinded to group allocation.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 14, 2021
First Posted
August 9, 2021
Study Start
November 1, 2021
Primary Completion
December 31, 2022
Study Completion
September 30, 2023
Last Updated
November 28, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share